Maxzide-25 recall: Superpotent
Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV…
Why was Maxzide-25 recalled?
Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 3087136, Exp 5/20
- Product
- Maxzide-25 (Triamterene and hydrochlorothiazide) tablets, USP, 37.5 mg/ 25 mg, 100-count bottle, Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV…
- Recalling firm
- Mylan Pharmaceuticals Inc.
- Quantity
- 1,620 bottles
- Distribution
- Product was distributed throughout the United States
- Recall date
- June 20, 2018
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)